These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 17962372

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
    Hamabe W, Maeda T, Fukazawa Y, Kumamoto K, Shang LQ, Yamamoto A, Yamamoto C, Tokuyama S, Kishioka S.
    Pharmacol Biochem Behav; 2006 Nov; 85(3):629-36. PubMed ID: 17134744
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
    Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV, Elmquist WF.
    J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro P-glycoprotein efflux inhibition by atypical antipsychotics is in vivo nicely reflected by pharmacodynamic but less by pharmacokinetic changes.
    Schmitt U, Kirschbaum KM, Poller B, Kusch-Poddar M, Drewe J, Hiemke C, Gutmann H.
    Pharmacol Biochem Behav; 2012 Aug; 102(2):312-20. PubMed ID: 22525746
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Progress in brain penetration evaluation in drug discovery and development.
    Liu X, Chen C, Smith BJ.
    J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.
    Ozgür B, Saaby L, Janfelt C, Langthaler K, Eneberg E, Jacobsen AM, Badolo L, Montanari D, Brodin B.
    Eur J Pharm Biopharm; 2021 Dec; 169():211-219. PubMed ID: 34756975
    [Abstract] [Full Text] [Related]

  • 32. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.
    Neuhaus W, Stessl M, Strizsik E, Bennani-Baiti B, Wirth M, Toegel S, Modha M, Winkler J, Gabor F, Viernstein H, Noe CR.
    Neurosci Lett; 2010 Jan 22; 469(2):224-8. PubMed ID: 19963040
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.
    Bundgaard C, Jensen CJ, Garmer M.
    Drug Metab Dispos; 2012 Mar 22; 40(3):461-6. PubMed ID: 22112383
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro models for the blood-brain barrier.
    Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD, Lindmark T, Mabondzo A, Nilsson JE, Raub TJ, Stanimirovic D, Terasaki T, Oberg JO, Osterberg T.
    Toxicol In Vitro; 2005 Apr 22; 19(3):299-334. PubMed ID: 15713540
    [Abstract] [Full Text] [Related]

  • 37. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
    Tang F, Ouyang H, Yang JZ, Borchardt RT.
    J Pharm Sci; 2004 May 22; 93(5):1185-94. PubMed ID: 15067695
    [Abstract] [Full Text] [Related]

  • 38. In-vitro evaluation of the P-glycoprotein interactions of a series of potentially CNS-active Amaryllidaceae alkaloids.
    Eriksson AH, Rønsted N, Güler S, Jäger AK, Sendra JR, Brodin B.
    J Pharm Pharmacol; 2012 Nov 22; 64(11):1667-77. PubMed ID: 23058055
    [Abstract] [Full Text] [Related]

  • 39. Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery.
    Balimane PV, Patel K, Marino A, Chong S.
    Eur J Pharm Biopharm; 2004 Jul 22; 58(1):99-105. PubMed ID: 15207543
    [Abstract] [Full Text] [Related]

  • 40. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
    Bachmeier CJ, Trickler WJ, Miller DW.
    Drug Metab Dispos; 2006 Jun 22; 34(6):998-1003. PubMed ID: 16554372
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.